These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51. 2-Alkoxycarbonylaminopyridines: inhibitors of Mycobacterium tuberculosis FtsZ. White EL; Suling WJ; Ross LJ; Seitz LE; Reynolds RC J Antimicrob Chemother; 2002 Jul; 50(1):111-4. PubMed ID: 12096015 [TBL] [Abstract][Full Text] [Related]
52. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis. Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494 [TBL] [Abstract][Full Text] [Related]
54. Direct inhibitors of InhA are active against Mycobacterium tuberculosis. Manjunatha UH; S Rao SP; Kondreddi RR; Noble CG; Camacho LR; Tan BH; Ng SH; Ng PS; Ma NL; Lakshminarayana SB; Herve M; Barnes SW; Yu W; Kuhen K; Blasco F; Beer D; Walker JR; Tonge PJ; Glynne R; Smith PW; Diagana TT Sci Transl Med; 2015 Jan; 7(269):269ra3. PubMed ID: 25568071 [TBL] [Abstract][Full Text] [Related]
55. Reappraising the use of β-lactams to treat tuberculosis. Kurz SG; Bonomo RA Expert Rev Anti Infect Ther; 2012 Sep; 10(9):999-1006. PubMed ID: 23106275 [TBL] [Abstract][Full Text] [Related]
56. Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country. Ahmad S; Mokaddas E; Al-Mutairi N; Eldeen HS; Mohammadi S PLoS One; 2016; 11(4):e0153563. PubMed ID: 27096759 [TBL] [Abstract][Full Text] [Related]
57. Routine Culture-Resistant Mycobacterium tuberculosis Rescue and Shell-Vial Assay, France. Fellag M; Saad J; Armstrong N; Chabrière E; Eldin C; Lagier JC; Drancourt M Emerg Infect Dis; 2019 Nov; 25(11):2131-2133. PubMed ID: 31625862 [TBL] [Abstract][Full Text] [Related]
58. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
59. A Collaborative Approach for "ReSeq-ing" Mycobacterium tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers. Schito M; Dolinger DL EBioMedicine; 2015 Oct; 2(10):1262-5. PubMed ID: 26629499 [No Abstract] [Full Text] [Related]
60. Pathogen-based precision medicine for drug-resistant tuberculosis. Gröschel MI; Walker TM; van der Werf TS; Lange C; Niemann S; Merker M PLoS Pathog; 2018 Oct; 14(10):e1007297. PubMed ID: 30335850 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]